Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
2212 | FCGR2A | Fc gamma receptor IIa | |
2321 | FLT1 | fms related receptor tyrosine kinase 1 | |
2629 | GBA1 | glucosylceramidase beta 1 | |
3075 | CFH | complement factor H | |
3091 | HIF1A | hypoxia inducible factor 1 subunit alpha | |
3117 | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | |
3119 | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | |
3383 | ICAM1 | intercellular adhesion molecule 1 | |
3426 | CFI | complement factor I | |
3558 | IL2 | interleukin 2 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
16153 | Il10 | interleukin 10 | |
16163 | Il13 | interleukin 13 | |
16164 | Il13ra1 | interleukin 13 receptor, alpha 1 | |
16171 | Il17a | interleukin 17A | |
16183 | Il2 | interleukin 2 | |
16187 | Il3 | interleukin 3 | |
16189 | Il4 | interleukin 4 | |
16414 | Itgb2 | integrin beta 2 | |
16542 | Kdr | kinase insert domain protein receptor | |
16592 | Fabp5 | fatty acid binding protein 5, epidermal |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
140868 | Fabp5 | fatty acid binding protein 5 | |
156767 | Tnfrsf1b | TNF receptor superfamily member 1B | |
287287 | Il4 | interleukin 4 | |
289211 | Fcgr2b | Fc gamma receptor 2B | |
297508 | Nampt | nicotinamide phosphoribosyltransferase | |
360687 | Cadm2 | cell adhesion molecule 2 | |
498276 | Fcgr2al1 | Fc gamma receptor 2A like 1 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
175182 | ver-1 | Protein ver-1 | |
175504 | pat-3 | Integrin beta pat-3 | |
177314 | gba-4 | Putative glucosylceramidase 4 | |
178535 | gba-3 | Putative glucosylceramidase 3 | |
181289 | ver-3 | Tyrosine-protein kinase receptor ver-3 | |
186632 | ver-4 | Tyrosine-protein kinase receptor ver-4 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024